The New Frontier in Neurological Research: Are GLP-1s Changing the Game?
GLP-1 receptor agonists are emerging as potential Alzheimer’s therapies, targeting metabolic dysfunction and inflammation, signaling a shift beyond amyloid-focused treatments despite mixed clinical trial results.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.